Drug
Insulin Aspart clinical trials
Also written NovoRapid, Novolog, NN1218 and Aspart.
- studies test it
- 231
- open now
- 7
- in phase 3
- 69
- first study started
- 1997
Keep track of what changes. Save the Insulin Aspart studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
229 studies that test it; most in 2010 (17)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 1998 | 1 |
| 1999 | 3 |
| 2000 | 4 |
| 2001 | 4 |
| 2002 | 16 |
| 2003 | 16 |
| 2004 | 16 |
| 2005 | 11 |
| 2006 | 9 |
| 2007 | 13 |
| 2008 | 11 |
| 2009 | 6 |
| 2010 | 17 |
| 2011 | 14 |
| 2012 | 7 |
| 2013 | 10 |
| 2014 | 11 |
| 2015 | 9 |
| 2016 | 10 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 9 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 68
- Phase 2
- 13
- Phase 3
- 69
- Phase 4
- 65
- No phase
- 18
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 168 · Other 63
Novo Nordisk A/S (148) · Medical University of Warsaw (4) · Arecor Limited (4) · Anna Stanhewicz, PhD (3) · Emory University (3) · Sanofi (3) · Medical University of Graz (3) · Amphastar Pharmaceuticals, Inc. (2)
Often tested with
Tested in the same studies.
Insulin degludec (39) · Insulin Detemir (20) · Insulin Glargine (18) · Insulin Lispro (14) · Insulin aspart, insulin aspart protamine drug combination 30:70 (11) · Insulin glulisine (10) · Insulin, Regular, Human (9) · Metformin (9)
Studies
Open first, then newest update. How each study uses Insulin Aspart is read from its arms, and is right about nine times in ten.
Testing it · 231
- Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDMRecruitingEarly Phase 1Anna Stanhewicz, PhDNCT06547619Written as Insulin aspart
- Oxidative Stress in Microvascular Dysfunction Following Gestational DiabetesRecruitingEarly Phase 1Anna Stanhewicz, PhDNCT05946785Written as insulin aspart
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 DiabetesNot yet recruitingPhase 4Yanbing LiNCT07173712Written as Insulin Degludec and Insulin Aspart Injection
- A Trial of Three- and Seven-days Insulin Infusions SetRecruitingNot applicableSteno Diabetes Center CopenhagenNCT06532461Written as Novorapid
- The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 DiabetesRecruitingPhase 4Sun Yat-sen UniversityNCT06127433Written as Insulin aspart
- Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With DiabetesRecruitingPhase 3Huashan HospitalNCT05641337Written as Insulin Degludec and Insulin Aspart
- Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 DiabetesRecruitingNot applicableDefymedNCT05221359Written as Insulin aspart
- Role of NADPH Oxidase in Microvascular Dysfunction Following GDMActive, not recruitingEarly Phase 1Anna Stanhewicz, PhDNCT05946798Written as Insulin aspart
- Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy VolunteersCompletedPhase 2/3Amphastar Pharmaceuticals, Inc.NCT07560150Written as I004
- Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational DiabetesActive, not recruitingPhase 2University of Alabama at BirminghamNCT04542148Written as Sliding Scale Insulin
- Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute HyperkalemiaCompletedPhase 4Nantes University HospitalNCT04012138Written as Insulin Aspart
- A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in ChinaCompletedPhase 3Sunshine Lake Pharma Co., Ltd.NCT05802862Written as Insulin Degludec and Insulin Aspart
- Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy VolunteersCompletedPhase 2/3Amphastar Pharmaceuticals, Inc.NCT05539872Written as I004
- Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin PumpCompletedPhase 3University Hospital, BrestNCT02546401Written as Insulin Aspart
- The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.CompletedPhase 4Medical University of WarsawNCT04124302Written as Insulin Aspart
- Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin AspartCompletedPhase 1Wake Forest University Health SciencesNCT02462161Written as Insulin aspart
- Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes MellitusCompletedPhase 3Boston Medical CenterNCT04460326Written as NovoLog
- AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp StudyCompletedPhase 1Arecor LimitedNCT05754424Written as NovoRapid
- Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00447382Written as insulin aspart
- A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and SafetyCompletedPhase 3Tonghua Dongbao Pharmaceutical Co.,LtdNCT02491528Written as insulin Aspart injection
See all 231 studies that test Insulin Aspart →
Given in every arm · 50 — Insulin Aspart is usual care beside what is tested
- CGM-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglycemia in Sudden Sensorineural Hearing Loss: SHIP TrialNot yet recruitingNot applicableHallym UniversityNCT07652528Written as Fast-acting Insulin Aspart (Fiasp)
- A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection ODRecruitingPhase 2Gan and Lee Pharmaceuticals, USANCT06558708Written as Insulin aspart
- A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesActive, not recruitingPhase 3Novo Nordisk A/SNCT07076199Written as Insulin aspart
- A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin PumpCompletedPhase 1Novo Nordisk A/SNCT06809621Written as Insulin aspart
- A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin PumpCompletedPhase 1Novo Nordisk A/SNCT07068295Written as Insulin Aspart
- A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)CompletedPhase 3Novo Nordisk A/SNCT04848480Written as insulin aspart
- A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)CompletedPhase 3Novo Nordisk A/SNCT04880850Written as Insulin aspart
- Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DMCompletedNot applicableBeijing HospitalNCT05417841Written as Insulin Degludec and Insulin Aspart Injection
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2DCompletedPhase 4The Cleveland ClinicNCT04538352Written as Insulin aspart
- Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineCompletedPhase 3SanofiNCT03874715Written as Insulin Aspart
- Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes SubjectsCompletedPhase 4Karolinska InstitutetNCT02621489Written as Humulin kwickpen
- Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03377699Written as Insulin Aspart
- Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial PancreasCompletedNot applicableMcGill UniversityNCT04163874Written as Fiasp
- A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes MellitusCompletedPhase 1SanofiNCT02910518Written as Insulin aspart
- Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 DiabetesCompletedPhase 4Emory UniversityNCT03336528Written as Aspart
- Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin GlargineCompletedPhase 3SanofiNCT03211858Written as Insulin aspart
- Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03268005Written as Faster-acting insulin aspart
- Use of NPH Versus Basal Bolus Insulin for Steroid Induced HyperglycemiaTerminatedPhase 4Northwestern UniversityNCT03511521Written as Insulin Aspart
- Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac SurgeryCompletedPhase 4Emory UniversityNCT02556918Written as Supplemental insulin (Insulin aspart)
- A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes MellitusCompletedPhase 3Novo Nordisk A/SNCT01513473Written as insulin aspart
Showing 20 of 50.
As the comparator · 44 — what is tested is compared with Insulin Aspart
- Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM PatientsRecruitingNot applicableBeijing HospitalNCT03987308Written as Insulin aspart
- A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 DiabetesCompletedPhase 1Novo Nordisk A/SNCT04698018Written as Novo Rapid
- Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With DiabetesCompletedPhase 3Novo Nordisk A/SNCT04588259Written as Insulin aspart
- Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DMCompletedNot applicableBeijing HospitalNCT05417841Written as Insulin Degludec and Insulin Aspart Injection
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)CompletedPhase 3Novo Nordisk A/SNCT05013229Written as insulin aspart
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)CompletedPhase 3SanofiNCT05413369Written as IDegAsp
- Afrezza® INHALE-1 Study in PediatricsCompletedPhase 3Mannkind CorporationNCT04974528Written as Rapid-acting Insulin Analog
- Simplified Insulin Regimen for the ElderlyTerminatedPhase 4University of MiamiNCT03660553Written as Insulin Aspart
- IDegLira HIGH TrialCompletedPhase 3Emory UniversityNCT03737240Written as Insulin Aspart
- Bioequivalence Study of INS062 and Pharmacokinetics and Pharmacokinetics Study of Single Injection of HR20014 in Healthy SubjectsStatus unknownPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT05719961Written as Insulin Aspart
- A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes MellitusCompletedPhase 1Novo Nordisk A/SNCT04655690Written as Fast-acting insulin aspart
- A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03689374Written as Insulin aspart
- Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes MellitusCompletedPhase 1SanofiNCT03916601Written as Insulin Aspart
- A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes MellitusCompletedPhase 1SanofiNCT03202875Written as Insulin Aspart
- Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin GlargineCompletedPhase 3SanofiNCT03211858Written as Insulin aspart
- Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03268005Written as Faster-acting insulin aspart
- A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes MellitusCompletedPhase 1/2AdociaNCT03981627Written as NovoRapid®
- Hyperglycemia in Renal TransplantationCompletedNot applicableUniversity of California, San FranciscoNCT01643382Written as Insulin, Asp(B28)-
- Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus PatientsCompletedPhase 2/3Biocon LimitedNCT03430856Written as Insulin Aspart
- A Meal Test Study of LY900014 in Participants With Type 1 Diabetes MellitusCompletedPhase 1Eli Lilly and CompanyNCT03449433Written as Insulin Aspart
Showing 20 of 44.
Codes
What other systems call Insulin Aspart · ClinicalTrials.gg INT008948
- MeSH (NLM) D061267Insulin AspartConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) D933668QVXINSULIN ASPARTConfirmed FDA, NLM
- RxNorm 51428One source FDA
- NCI Thesaurus C47563Insulin AspartOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D061267 | Insulin Aspart | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | D933668QVX | INSULIN ASPART | Confirmed FDA, NLM |
| RxNorm | 51428 | — | One source FDA |
| NCI Thesaurus | C47563 | Insulin Aspart | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.